CD274 and neoplasm: From the results of the correlation analyses between the CRS classifications and clinicopathological features or immunity characteristics of the tumour microenvironment, we propose that the model can predict tumour progression and thus could be used to guide the choices of chemotherapy and PD-L1-targeted immunotherapy treatment for patients with BLCA.